U.S. Food and Staples Retail Stock News

StubHub Holdings stock reaction and recent performance StubHub Holdings (STUB) has drawn investor attention after recent trading, with the stock last closing at $9.73. The move comes as the company reports annual revenue of $1,793.63 million alongside a net loss of $1,923.97 million. See our latest analysis for StubHub Holdings. After a mixed few months, StubHub Holdings has seen a 36.08% 30 day share price return, although the year to date share price return is still down 31.91%. This...

MiniMed Group (NasdaqGS:MMED) released peer reviewed clinical data showing its insulin pump algorithm maintains consistent glycemic outcomes across different glucose sensors. The study is backed by extensive real world evidence, covering thousands of patients using MiniMed’s automated insulin delivery platform. Findings point to the algorithm as the main driver of glycemic control, rather than the specific sensor paired with the pump. MiniMed Group, trading at $11.18, is drawing attention...

JOYY (NasdaqGS:JOYY) just posted Q1 2026 results with revenue of US$555.7 million and basic EPS of US$1.00, while trailing twelve month figures show revenue of about US$2.2 billion and a net loss of US$1.6 billion, which points to pressure on overall profitability despite the latest quarterly profit. The company has seen quarterly revenue move from US$494.4 million in Q1 2025 to US$555.7 million in Q1 2026, with basic EPS shifting from US$36.08 to around US$1.00 over the same period as...

For investors wondering whether Birkenstock Holding at around US$43.54 represents a bargain or a value trap, this article walks through what the current price implies. The stock has moved sharply in the short term, with a 34.0% gain over the last 7 days and 10.5% over the last month, even though the return over the past year is down 19.6%. Recent coverage has focused on Birkenstock Holding as a newly public footwear brand with a long heritage, highlighting investor interest in how a classic...

FinVolution Group (NYSE:FINV) opened 2026 earnings season with Q1 results that sit against a recent run of solid scale, with Q4 2025 revenue at about C¥3.1b and basic EPS of C¥1.71 off net income of C¥424.7m. This sets a clear reference point for how the new quarter will be judged. Over the past few quarters the company has seen revenue move from C¥3.5b in Q4 2024 to C¥3.6b in Q2 2025 before settling at C¥3.1b in Q4 2025. Over the same span, quarterly EPS ranged between C¥1.71 and C¥2.95,...

AutoZone (AZO) has just posted its Q2 2026 results with total revenue of US$4.3b, basic EPS of US$28.29 and net income of US$468.86m, while same store sales growth for the quarter came in at 3.3%. Over the last few quarters the company has seen revenue move from US$4.0b and EPS of US$29.06 in Q2 2025 to US$4.3b and EPS of US$28.29 in Q2 2026, with trailing twelve month revenue at US$19.6b and EPS at US$146.68 providing the broader context. Against this backdrop, a trailing net margin of 12.5%...

Universal Health Services (NYSE:UHS) announced the resignation of Matthew J. Peterson as Executive Vice President and President of Behavioral Health. The company stated that its Chief Executive Officer will assume interim oversight of the Behavioral Health division following Peterson's departure. This leadership change affects a core business unit that focuses on behavioral health services across the Universal Health Services network. Universal Health Services operates acute care hospitals...

Beam Therapeutics reported new clinical data from its BEAM-302 Phase 1/2 trial in alpha-1 antitrypsin deficiency, showing encouraging safety and efficacy signals. Based on FDA feedback, the company plans to pursue an accelerated approval pathway and start a pivotal cohort for BEAM-302. Beam intends to share more detailed BEAM-302 data later in the year, positioning this program as a key focus in its gene editing pipeline. For investors tracking NasdaqGS:BEAM, this update highlights BEAM-302...

The United States market has shown robust performance recently, with a 1.2% increase over the past week and a substantial 29% rise over the last year, while earnings are projected to grow by 17% annually. In this environment, identifying high growth tech stocks involves looking for companies that not only capitalize on current technological trends but also demonstrate strong potential for sustained revenue and earnings growth.

The market has climbed 1.2% in the last 7 days and an impressive 29% over the past year, with earnings forecasted to grow by 17% annually. While penny stocks might seem like a relic from earlier market eras, they offer a unique opportunity for growth at lower price points, especially when backed by strong balance sheets and solid fundamentals. In this article, we explore several penny stocks that stand out as hidden gems with potential for impressive returns.

The United States market has shown impressive growth, rising 1.2% over the last week and 29% over the past year, with earnings projected to increase by 17% annually in the coming years. In this thriving environment, identifying stocks that are not only poised for growth but also remain underappreciated can present unique opportunities for investors seeking to capitalize on emerging potential.

Healthcare Realty Trust (HR) has arranged a new US$400 million senior unsecured delayed draw term loan, giving the company committed capital through 2029 with the option to increase the facility by up to US$100 million. See our latest analysis for Healthcare Realty Trust. At a share price of US$20.36, Healthcare Realty Trust has seen a 30 day share price return of 8.82% and a year to date share price return of 20.12%. The 1 year total shareholder return of 47.43% points to strong recent...

Dole PLC reported its Q1 2026 results earlier this month, with revenue rising about 12% year over year while net income fell as higher expenses offset strong demand, higher fruit prices, and helpful foreign exchange movements. At the same time, Dole outlined around US$100 million of planned investment in automation, artificial intelligence, and advanced warehouse solutions in Sweden, alongside bolt-on acquisition activity in Italy, Sweden, Spain, and Ireland, pointing to a push for greater...

Quanta Services (NYSE:PWR) has appointed Joseph Kim to its Board of Directors, adding operational and supply chain experience to its governance structure. The company has also approved a new share repurchase program authorizing up to $1b of stock buybacks. These actions reflect recent company decisions that have not been widely discussed and are likely to interest existing and potential shareholders. Quanta Services is making these moves with its stock trading at $723.44, following multi...

LexinFintech Holdings (NasdaqGS:LX) opened 2026 with Q1 revenue of C¥3.3b and basic EPS of C¥1.21, against a trailing twelve month EPS of C¥8.59 and net income of C¥1,448.19m that translated into a 10.8% net margin over the past year. The company reported quarterly revenue of C¥3.10b in Q1 2025 and C¥3.31b in Q1 2026, while basic EPS went from C¥2.55 to C¥1.21 over the same period. This frames the latest results in the context of a year of 9% earnings growth and an improved margin profile...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Crane NXT...

Some Xometry, Inc. ( NASDAQ:XMTR ) shareholders may be a little concerned to see that the Co-Founder, Randolph...

If you are wondering whether Option Care Health stock is starting to look interesting at current levels, the key question is how its price compares with its underlying value. The stock last closed at US$20.93, with the share price edging up 0.3% over the past week but declining 26.3% over the past month and 35.1% year to date, contributing to a 34.8% decline over the last year. Recent coverage around Option Care Health has focused on its share price performance and what it might imply about...

Some Navigator Holdings Ltd. ( NYSE:NVGS ) shareholders may be a little concerned to see that the Chief Operating...

We wouldn't blame Loar Holdings Inc. ( NYSE:LOAR ) shareholders if they were a little worried about the fact that Taiwo...

Over the last 7 days, the United States market has risen by 1.2% and over the past 12 months, it is up by an impressive 29%, with earnings forecasted to grow annually by 17%. In this thriving environment, identifying small-cap stocks with insider buying can present intriguing opportunities for investors seeking potential value in a dynamic market landscape.

The United States market has shown robust performance, climbing 1.2% in the last week and rising 29% over the past year, with earnings projected to grow by 17% annually in the coming years. In such a thriving environment, identifying stocks that are trading below their intrinsic value can present attractive opportunities for investors seeking potential long-term gains.

Last week's profit announcement from LuxExperience B.V. ( NYSE:LUXE ) was underwhelming for investors, despite headline...

The United States market has experienced a robust performance, with a 1.2% increase over the last week and a substantial 29% rise over the past year, while earnings are anticipated to grow by 17% annually in the coming years. In this environment, growth companies with significant insider ownership can be particularly appealing as they often align management interests with shareholder value and may indicate confidence in the company's future prospects.